Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-24 2:02 pm Purchase | 2024-09-30 | 13G | Verastem, Inc. VSTM | BlackRock Inc. BLK | 2,234,699 5.600% | 2,234,699 (New Position) | Filing History |
| 2024-07-29 4:04 pm Purchase | 2024-07-24 | 13G | Verastem, Inc. VSTM | Stonepine Capital Management LLC | 2,666,666 6.700% | 2,666,666 (New Position) | Filing History |
| 2024-02-14 7:31 pm Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 1,529,115 6.100% | 1,529,115 (New Position) | Filing History |
| 2024-02-14 10:00 am Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | Viking Global Investors LP | 2,531,829 9.990% | 1,211,173 (+91.71%) | Filing History |
| 2024-02-14 09:20 am Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 2,617,402 9.990% | 2,617,402 (New Position) | Filing History |
| 2024-02-13 5:01 pm Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | Vivo Opportunity LLC | 1,538,461 6.100% | 1,538,461 (New Position) | Filing History |
| 2024-02-02 09:49 am Purchase | 2023-12-31 | 13G | Verastem, Inc. VSTM | Soleus Capital Master Fund, L.P. | 1,425,634 6.800% | 128,265 (+9.89%) | Filing History |
| 2023-08-31 5:28 pm Purchase | 2023-08-21 | 13G | Verastem, Inc. VSTM | ADAGE CAPITAL PARTNERS GP L.L.C. | 1,300,000 5.150% | 1,300,000 (New Position) | Filing History |
| 2023-08-10 4:39 pm Sale | 2023-07-31 | 13G | Verastem, Inc. VSTM | BAKER BROS. ADVISORS LP | 0 0.000% | -1,345,192 (Position Closed) | Filing History |
| 2023-07-27 4:30 pm Purchase | 2023-07-26 | 13G | Verastem, Inc. VSTM | Soleus Capital Master Fund, L.P. | 1,297,369 5.100% | 1,297,369 (New Position) | Filing History |
| 2023-06-22 5:46 pm Purchase | 2023-06-21 | 13G | Verastem, Inc. VSTM | Flynn James E | 1,538,461 6.100% | 1,538,461 (New Position) | Filing History |
| 2023-06-12 4:37 pm Purchase | 2023-05-31 | 13G | Verastem, Inc. VSTM | BAKER BROS. ADVISORS LP | 1,345,192 8.000% | 1,345,192 (New Position) | Filing History |
| 2023-06-05 5:00 pm Purchase | 2023-05-26 | 13G | Verastem, Inc. VSTM | Viking Global Investors LP | 1,320,656 7.900% | 1,320,656 (New Position) | Filing History |
| 2023-02-14 5:16 pm Purchase | 2022-12-31 | 13G | Verastem, Inc. VSTM | ORBIMED ADVISORS LLC | 1,375,270 7.900% | 1,375,270 (New Position) | Filing History |
| 2023-02-14 4:00 pm Purchase | 2022-12-31 | 13G | Verastem, Inc. VSTM | BAKER BROS. ADVISORS LP | 2,249,075 13.500% | 458,106 (+25.58%) | Filing History |
| 2023-02-13 8:16 pm Purchase | 2022-12-31 | 13G | Verastem, Inc. VSTM | BIOTECHNOLOGY VALUE FUND L P | 1,674,539 9.990% | 132,359 (+8.58%) | Filing History |
| 2022-07-08 4:57 pm Sale | 2022-06-30 | 13G | Verastem, Inc. VSTM | BlackRock Inc. BLK | 361,445 2.300% | -665,910 (-64.82%) | Filing History |
| 2022-02-14 4:16 pm Purchase | 2021-12-31 | 13G | Verastem, Inc. VSTM | BAKER BROS. ADVISORS LP | 1,790,969 11.800% | 233,828 (+15.02%) | Filing History |
| 2022-02-10 08:42 am Sale | 2021-12-31 | 13G | Verastem, Inc. VSTM | VANGUARD GROUP INC | 737,483 4.860% | -13,565 (-1.81%) | Filing History |
| 2022-02-03 4:41 pm Sale | 2021-12-31 | 13G | Verastem, Inc. VSTM | BlackRock Inc. BLK | 1,027,354 6.800% | -96,956 (-8.62%) | Filing History |